FRAMINGHAM (10/21/2003) - Drug discovery company Inpharmatica Ltd. has entered into a two-year agreement with biopharmaceutical company British Biotech, which will use Inpharmatica absorption, distribution, metabolism, and excretion (ADME) services in its drug discovery process. As part of the deal, an Inpharmatica ADME consultant will join British Biotech research projects and manage the joint ADME work carried out by an Inpharmatica team. This team will provide assays, analysis, and interpretation of ADME data for a number of British Biotech drugs that are in its pipeline. The financial terms of the deal were not revealed.
- Free Whitepaper! Learn how to create an analytics environment that is governed, scalable and self-serve.
- Free Whitepaper! The 5 criteria to help you select the right analytics platform for your organization.
- Free Whitepaper! Learn how IT is evolving from producer to enabler, and fostering collaboration around analytics.